Boardminder

    N. Anthony Coles, M.D.

    1 board
    Healthcare
    As of 8/31/2026

    0.34

    Boardminder Score™

    Bottom 46% of 4,262 directors

    Lower scoreHigher score

    9.7

    Avg Tenure (yrs)

    Shorter tenure than 32% of directors

    ShorterLonger

    $107K

    Total Compensation

    Lower than 76% of 3,007 one-seat directors

    LowerHigher
    Board Seats Breakdown
    Regeneron Pharmaceuticals, Inc.
    REGN
    F500 #309
    Director
    Healthcare
    Seat Score
    0.34
    Tenure
    9.7 yrs
    Compensation
    $107K
    Excess Return
    -64.7%